Found: 3
Select item for more details and to access through your institution.
Is autophagy induction by PARP inhibitors a target for therapeutic benefit?
- Published in:
- Oncology Research, 2022, v. 30, n. 1, p. 1, doi. 10.32604/or.2022.026459
- By:
- Publication type:
- Article
Pilot clinical trial and phenotypic analysis in chemotherapy-pretreated, metastatic triple-negative breast cancer patients treated with oral TAK-228 and TAK-117 (PIKTOR) to increase DNA damage repair deficiency followed by cisplatin and nab paclitaxel.
- Published in:
- Biomarker Research, 2023, v. 11, n. 1, p. 1, doi. 10.1186/s40364-023-00511-7
- By:
- Publication type:
- Article
Unexpected Clinical Outcome for Myxoinflammatory Fibroblastic Sarcoma, When Should They Be Considered High Grade?
- Published in:
- Journal of Investigative Medicine High Impact Case Reports, 2023, p. 1, doi. 10.1177/23247096231205344
- By:
- Publication type:
- Article